Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection

Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection

Abstract Purpose The prognostic value of pretreatment and preoperative fibrinogen plasma levels and the modified Glasgow prognostic score (mGPS) in stage III/N2 non-small cell lung cancer (NSCLC) patients who receive neoadjuvant treatment followed by radical surgery is yet unclear. Methods Fibrinoge...

Full description

Bibliographic Details
Main Authors: Katharina Sinn, Berta Mosleh, Michael Grusch, Walter Klepetko, Konrad Hoetzenecker, Thomas Klikovits, Daniela Gompelmann, Mir Alireza Hoda
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Cancer
Subjects:
Non-small-cell lung cancer
Fibrinogen
mGPS
N2 disease
Stage III
Online Access:https://doi.org/10.1186/s12885-022-10298-9

Internet

https://doi.org/10.1186/s12885-022-10298-9

Similar Items